Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol

REFERENCES

• Yang, H.; Chen, D.; Cui, Q.C.; Yuan, X.; Dou, Q.P. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 2006, 66(9), 4758–4765.
   PubMed Web of Science ®Google Scholar
• Zhang, T.; Hamza, A.; Cao, X.; Wang, B.; Yu, S.; Zhan, C.-G.; Sun, D. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther 2008, 7(1), 162–170.
   PubMed Web of Science ®Google Scholar
• Zhang, X.D.; Nguyen, T.; Thomas, W.D.; Sanders, J.E.; Hersey, P. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 2000, 482(3), 193–199.
   PubMed Web of Science ®Google Scholar
• Pan, G.; Ni, J.; Wei, Y.F.; Yu, G.; Gentz, R.; Dixit, V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997, 277(5327), 815–818.
   PubMed Web of Science ®Google Scholar
• Pan, G.; O'Rourke, K.; Chinnaiyan, A.M.; Gentz, R.; Ebner, R.; Ni, J.; Dixit, V.M. The receptor for the cytotoxic ligand TRAIL. Science 1997, 276(5309), 111–113.
   PubMed Web of Science ®Google Scholar
• Sheridan, J.P.; Marsters, S.A.; Pitti, R.M.; Gurney, A.; Skubatch, M.; Baldwin, D.; Ramakrishnan, L.; Gray, C.L.; Baker, K.; Wood, W.I.; Goddard, A.D.; Godowski, P.; Ashkenazi, A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277(5327), 818–821.
   PubMed Web of Science ®Google Scholar
• Ozoren, N.; Fisher, M.J.; Kim, K.; Liu, C.X.; Genin, A.; Shifman, Y.; Dicker, D.T.; Spinner, N.B.; Lisitsyn, N.A.; El-Deiry, W.S. Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 2000, 16(5), 917–925.
   PubMed Web of Science ®Google Scholar
• Wang, S.; El-Deiry, W.S. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003, 22(53), 8628–8233.
   PubMed Web of Science ®Google Scholar
• Cuello, M.; Ettenberg, S.A.; Nau, M.M.; Lipkowitz, S. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Gynecol Oncol 2001, 81(3), 380–390.
   PubMed Web of Science ®Google Scholar
• Ray, S.; Shyam, S.; Fraizer, G.C.; Almasan, A. S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. Mol Cancer Ther 2007, 6(4), 1368–1378.
   PubMed Web of Science ®Google Scholar
• Jung, E.M.; Lim, J.H.; Lee, T.J.; Park, J.-W.; Choi, K.S.; Kwon, T.K. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 2005, 26(11), 1905–1913.
   PubMed Web of Science ®Google Scholar
• Luo, P.; He, Q.; He, X.; Hu, Y.; Lu, W.; Cheng, Y.; Yang, B. Potent antitumor activity of 10-methoxy-9-nitrocamptothecin. Mol Cancer Ther 2006, 5(4), 962–968.
   PubMed Web of Science ®Google Scholar
• Yang, F.; Chen, Y.; Duan, W.; Zhang, C.; Zhu, H.; Ding, J. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor. Int J Cancer 2006, 119(5), 1184–1193.
   PubMed Web of Science ®Google Scholar
• Chou, T.C.; Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984, 22, 27–55.
   PubMedGoogle Scholar
• Chou, T.C.; Talalay, P. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem 1981, 115, 207–216.
   PubMedGoogle Scholar
• Kang, M.H.; Kang, Y.H.; Szymanska, B.; Wilczynska-Kalak U.; Sheard M.A.; Harned T.M.; Lock R.B.; Reynolds C.P. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 2007, 110(6), 2057–2066.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ruiz, C.; Lopez-Rivas, A. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells. Biochem J 2002, 365(Pt 3), 825–832.
   PubMedGoogle Scholar
• Sandra, F.; Hendarmin, L.; Nakao, Y.; Nakamura, N.; Nakamura, S. TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma. Tumour Biol 2005, 26(5), 258–264.
   PubMed Web of Science ®Google Scholar
• Ashkenazi, A.; Dixit, V.M. Death receptors: signaling and modulation. Science 1998, 281(5381), 1305–1308.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W.S. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ 2001, 8(11), 1066–1075.
   PubMed Web of Science ®Google Scholar
• Ashkenazi, A.; Pai, R.C.; Fong, S.; Leung, S.; Lawrence, D.A.; Marsters, S.A.; Blackie, C.; Chang, L.; McMurtrey, A.E.; Hebert, A.; DeForge, L.; Koumenis, I.L.; Lewis, D.; Harris, L.; Bussiere, J.; Koeppen, H.; Shahrokh, Z.; Schwall, R.H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999, 104(2), 155–162.
   PubMed Web of Science ®Google Scholar
• Keane, M.M.; Ettenberg, S.A.; Nau, M.M.; Russell, E.K.; Lipkowitz, S. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 1999, 59(3), 734–741.
   PubMed Web of Science ®Google Scholar
• Kim, M.; Liao, J.; Dowling, M.L.; Voong, K.R.; Parker, S.E.; Wang, S.; El-Deiry, W.S.; Kao, G.D. TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells. Cancer Res 2008, 68(9), 3440–3449.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Gu, J.; Lin, T.; Huang, X.; Roth, J.A.; Fang, B. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Gene Ther 2002, 9(18), 1262–1270.
   PubMed Web of Science ®Google Scholar
• Nagase, M.; Oto, J.; Sugiyama, S.; Yube, K.; Takaishi, Y.; Sakato, N. Apoptosis induction in HL-60 cells and inhibition of topoisomerase II by triterpene celastrol. Biosci Biotechnol Biochem 2003, 67(9), 1883–1887.
   PubMed Web of Science ®Google Scholar
• Sethi, G.; Ahn, K.S.; Pandey, M.K.; Aggarwal, B.B. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 2007, 109(7), 2727–2735.
   PubMed Web of Science ®Google Scholar
• Ashkenazi, A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002, 2(6), 420–430.
   PubMed Web of Science ®Google Scholar
• Zhao, L.; Wientjes, M.G.; Au, J.L.S. Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin Cancer Res 2004, 10(23), 7994–8004.
   PubMed Web of Science ®Google Scholar